Doxsaliform: A Novel N-Mannich Base Prodrug of a Doxorubicin Formaldehyde Conjugate

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|1|3|247-255

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.1, Iss.3, 2004-07, pp. : 247-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HPLC-MS/MS determination of a peptide conjugate prodrug of doxorubicin, and its active metabolites, leucine-doxorubicin and doxorubicin, in dog and rat plasma

By Mazuel C.   Grove J.   Gerin G.   Keenan K.P.  

Journal of Pharmaceutical and Biomedical Analysis, Vol. 33, Iss. 5, 2003-12 ,pp. : 1093-1102

Elsevier

Access to resources Recommend Favorite

A Novel Doxorubicin Prodrug with Controllable Photolysis Activation for Cancer Chemotherapy

By Ibsen Stuart   Zahavy Eran   Wrasdilo Wolf   Berns Michael   Chan Michael   Esener Sadik  

Pharmaceutical Research, Vol. 27, Iss. 9, 2010-09 ,pp. : 1848-1860

Springer Publishing Company

Access to resources Recommend Favorite

Novel Thioester Prodrug of N-acetylcysteine for Odor Masking and Bioavailability Enhancement

By  

Current Drug Delivery, Vol. 13, Iss. 4, 2016-06 ,pp. : 611-620

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis and In Vitro Cytotoxic Activity Evaluation of Novel Mannich Bases and Modified AZT Derivatives Possessing Mannich Base Moieties via Click Chemistry

By  

Letters in Drug Design & Discovery, Vol. 10, Iss. 7, 2013-08 ,pp. : 585-593

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the tumor targeting of a FAPαα-based doxorubicin prodrug

By Huang Sichao   Fang Rui   Xu Jun   Qiu Shenghong   Zhang Huan   Du Jun   Cai Shaohui  

Journal of Drug Targeting, Vol. 19, Iss. 7, 2011-08 ,pp. : 487-496

Informa Healthcare

Access to resources Recommend Favorite